JPMorgan Chase & Co. Has $157.68 Million Stock Holdings in Nutrien Ltd. $NTR

JPMorgan Chase & Co. grew its stake in Nutrien Ltd. (NYSE:NTRFree Report) by 6.4% in the 3rd quarter, Holdings Channel.com reports. The fund owned 2,685,813 shares of the company’s stock after purchasing an additional 160,549 shares during the quarter. JPMorgan Chase & Co.’s holdings in Nutrien were worth $157,684,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Root Financial Partners LLC bought a new stake in Nutrien during the third quarter worth about $37,000. Huntington National Bank increased its position in shares of Nutrien by 72.6% during the 2nd quarter. Huntington National Bank now owns 656 shares of the company’s stock worth $38,000 after purchasing an additional 276 shares during the last quarter. Geneos Wealth Management Inc. increased its position in shares of Nutrien by 42.4% during the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after purchasing an additional 219 shares during the last quarter. Acadian Asset Management LLC bought a new stake in shares of Nutrien during the 1st quarter worth approximately $54,000. Finally, Bessemer Group Inc. boosted its holdings in shares of Nutrien by 27.7% in the 3rd quarter. Bessemer Group Inc. now owns 937 shares of the company’s stock valued at $55,000 after buying an additional 203 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Stock Performance

NYSE NTR opened at $71.19 on Friday. The stock has a market cap of $34.27 billion, a PE ratio of 15.28 and a beta of 0.73. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.89 and a current ratio of 1.41. The firm has a 50-day moving average of $66.23 and a 200-day moving average of $60.67. Nutrien Ltd. has a 52-week low of $45.78 and a 52-week high of $73.55.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.04). The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.46%. The firm’s revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.31 earnings per share. On average, sell-side analysts anticipate that Nutrien Ltd. will post 3.72 EPS for the current year.

Nutrien Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a $0.55 dividend. This is a boost from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date is Tuesday, March 31st. This represents a $2.20 annualized dividend and a yield of 3.1%. Nutrien’s dividend payout ratio is presently 46.78%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on NTR. Zacks Research upgraded shares of Nutrien from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 27th. Raymond James Financial lifted their price objective on shares of Nutrien from $68.00 to $74.00 and gave the company a “market perform” rating in a research report on Friday. Mizuho upped their target price on shares of Nutrien from $65.00 to $68.00 and gave the company a “neutral” rating in a report on Friday, January 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Nutrien in a research note on Monday, December 29th. Finally, Barclays lifted their price target on Nutrien from $64.00 to $70.00 and gave the stock an “equal weight” rating in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $70.11.

Read Our Latest Stock Analysis on NTR

Trending Headlines about Nutrien

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Multiple broker upgrades and higher price targets — BMO raised its target to $85 (outperform), JPMorgan to $78 (overweight), Wells Fargo to $77 (equal weight) and Raymond James to $74, signaling analyst confidence in Nutrien’s outlook and suggesting meaningful upside from recent levels. BayStreet.CA Benzinga
  • Positive Sentiment: Shareholder returns: Nutrien raised its quarterly dividend (to $0.55) and announced a new buyback program — a direct positive for investors seeking yield and capital return. TipRanks
  • Positive Sentiment: Favorable commodity outlook: Management expects stronger global potash demand in 2026 despite difficult farm economics — a revenue/volume tailwind for Nutrien’s fertilizer segment. Reuters
  • Neutral Sentiment: Earnings materials available — full Q4 2025 call transcript and presentation have been published for investor review; useful for drilling into segment-level detail but not a directional catalyst by itself. Seeking Alpha Yahoo Finance
  • Neutral Sentiment: Some analysts remain cautious: Bank of America raised its target to $71 but kept a neutral rating (minimal implied upside). That tempers the bullish momentum from higher targets. Benzinga
  • Negative Sentiment: Operational results missed consensus: Q4 EPS came in at $0.83 vs. $0.87 expected and revenue of ~$5.12B was slightly below estimates — the earnings miss is the primary near-term negative pressure on the share price. Zacks
  • Negative Sentiment: Mixed analyst views persist — UBS assigned a “hold,” which indicates some investors and brokers are reserving judgment despite the positive catalysts. Globe & Mail

About Nutrien

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Read More

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.